Orin Green Financial’s DexCom DXCM Stock Holding History

Orin Green Financial’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$474K	Buy	7,038 +498	+8%	+$33.2K	0.17%	59
2026 Q1	$411K	Hold	6,540	–	–	0.17%	59
2025 Q4	$434K	Hold	6,540	–	–	0.17%	57
2025 Q3	$440K	Hold	6,540	–	–	0.18%	57
2025 Q2	$571K	Hold	6,540	–	–	0.24%	52
2025 Q1	$432K	Buy	+6,540	New	+$534K	0.2%	55
2024 Q4	–	Sell	-6,540	Closed	-$484K	–	52
2024 Q3	$438K	Buy	6,540 +1,759	+37%	+$144K	0.19%	57
2024 Q2	$542K	Buy	+4,781	New	+$604K	0.25%	48
2024 Q1	–	Sell	-4,559	Closed	-$573K	–	43
2023 Q4	$566K	Hold	4,559	–	–	0.28%	44
2023 Q3	$425K	Hold	4,559	–	–	0.24%	48
2023 Q2	$586K	Hold	4,559	–	–	0.31%	42
2023 Q1	$530K	Buy	4,559 +15	+0.3%	+$1.68K	0.29%	43
2022 Q4	$515K	Hold	4,544	–	–	0.3%	42
2022 Q3	$366K	Hold	4,544	–	–	0.24%	46
2022 Q2	$356K	Hold	4,544	–	–	0.22%	49
2022 Q1	$581K	Hold	4,544	–	–	0.38%	42
2021 Q4	$502K	Hold	4,544	–	–	0.36%	40
2021 Q3	$621K	Sell	4,544 -980	-18%	-$124K	0.43%	42
2021 Q2	$590K	Hold	5,524	–	–	0.42%	41
2021 Q1	$496K	Hold	5,524	–	–	0.4%	41
2020 Q4	$511K	Buy	+5,524	New	+$493K	0.41%	40

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Orin Green Financial's DXCM Position: Q2 2026 in Review

Orin Green Financial increased its DexCom (DXCM) stake by 7.6% in Q2 2026, buying an estimated $33.2K and bringing the position to 7,038 shares worth $474K. The position accounts for 0.17% of the portfolio, ranked #59.

Orin Green Financial first reported a position in DXCM in Q4 2020 and has held it in 21 quarters since. The position peaked at $621K in Q3 2021. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Orin Green Financial held 7,038 shares of DexCom worth $474K as of Q2 2026.
Orin Green Financial bought 498 DexCom shares in Q2 2026, an estimated $33.2K.
DexCom made up 0.17% of Orin Green Financial's portfolio in Q2 2026, its #59 holding.
Orin Green Financial first reported a position in DexCom in Q4 2020 and has held it in 21 quarters since.
Orin Green Financial's DexCom position peaked at $621K in Q3 2021.
968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Orin Green Financial's 13F filing for Q2 2026, filed 13 Jul 2026.